NCT00815438

Brief Summary

Surgical removal of the gallbladder is needed in 1 million people per year in the USA. The procedure is done by placing four tubes (cannula) from 5 to 10 mm through the abdominal wall. Air is placed in the abdominal cavity and a lighted scope is placed through one cannula. The space in the abdominal cavity can then be seen on a video screen. Thin retractors and dissecting instruments are placed through the other cannula and the gallbladder is removed using the video screen for vision. The gallbladder duct and the artery are usually occluded with clips or stitches. In this study we propose to do the procedure though a single 5 mm incision placed at the umbilicus and a second access through the vagina using a flexible endoscope. The gallbladder will be retracted using strings (sutures) attached to the gallbladder. The dissection will be done using laparoscopic instruments (scissors, knives, dissectors) placed through the laparoscopic port. A flexible grasper may be used in the endoscope to help with retraction. An endoscopic snare or grasper will be used to grasp the gallbladder and remove it from the abdomen through the vagina. This study evaluates the ability to do laparoscopic cholecystectomy with one skin incision and one vaginal incision. This will provide the basis for future studies evaluating decreased pain and costs with transvaginal assisted cholecystectomy.

Trial Health

15
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Timeline
Completed

Started Jan 2009

Typical duration for phase_1

Status
withdrawn

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 29, 2008

Completed
1 day until next milestone

First Posted

Study publicly available on registry

December 30, 2008

Completed
2 days until next milestone

Study Start

First participant enrolled

January 1, 2009

Completed
2.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2011

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2011

Completed
Last Updated

September 30, 2016

Status Verified

September 1, 2016

Enrollment Period

2.3 years

First QC Date

December 29, 2008

Last Update Submit

September 29, 2016

Conditions

Keywords

TransvaginalCholecystectomyNOTESEndoscopic

Outcome Measures

Primary Outcomes (1)

  • Reduction in the number of laparoscopic ports

    Time of surgery

Secondary Outcomes (3)

  • Cost analysis comparison of surgical procedures.

    Cost analysis will be done at end of study.

  • Time of procedure

    Time recorded during surgical procedure.

  • Cosmesis and pain

    Prior to procedure, 1 to 3 days post op, 7 to 10 days post op, and at follow-up visit ~6 weeks

Study Arms (1)

Surgical Procedure

EXPERIMENTAL

Laparoscopic transvaginal cholecystectomy with endoscopic assistance.

Procedure: cholecystectomy.

Interventions

Patients enrolled in the study will have a flexible transvaginal endoscopy used during laparoscopic cholecystectomy.

Also known as: Gallbladder removal
Surgical Procedure

Eligibility Criteria

Age18 Years - 80 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Female age ≥ 18 yrs
  • Diagnosis of cholelithiasis, cholecystectomy, choledocholithiasis or biliary dyskinesia and scheduled for laparoscopic cholecystectomy
  • Have an indication for a standard laparoscopic procedure cholecystectomy
  • Not pregnant

You may not qualify if:

  • Any significant co-morbidities, including significant cardiac disease, history of stroke, severe pulmonary disease, hypertension with a diastolic greater than 100, pancreatitis.
  • Patients that are immunosuppressed or on immunosuppression therapy.
  • An unacceptable psychological or medical risk as determined by the primary investigators.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

CholelithiasisCholecystitisBiliary Dyskinesia

Interventions

Cholecystectomy

Condition Hierarchy (Ancestors)

Biliary Tract DiseasesDigestive System DiseasesGallbladder DiseasesCommon Bile Duct DiseasesBile Duct Diseases

Intervention Hierarchy (Ancestors)

Biliary Tract Surgical ProceduresDigestive System Surgical ProceduresSurgical Procedures, Operative

Study Officials

  • Brent Miedema, MD

    University of Missouri-Columbia

    PRINCIPAL INVESTIGATOR
0

Study Design

Study Type
interventional
Phase
phase 1
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 29, 2008

First Posted

December 30, 2008

Study Start

January 1, 2009

Primary Completion

May 1, 2011

Study Completion

May 1, 2011

Last Updated

September 30, 2016

Record last verified: 2016-09

Data Sharing

IPD Sharing
Will not share